Annual Revenue
$1.10 M
-$2.09 M-65.62%
December 31, 2023
Summary
- As of February 7, 2025, MTNB annual revenue is $1.10 million, with the most recent change of -$2.09 million (-65.62%) on December 31, 2023.
- During the last 3 years, MTNB annual revenue has risen by +$937.70 thousand (+592.36%).
- MTNB annual revenue is now -65.62% below its all-time high of $3.19 million, reached on December 31, 2022.
Performance
MTNB Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
N/A
September 30, 2024
Summary
- MTNB quarterly revenue is not available.
Performance
MTNB Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 30, 2024
Summary
- MTNB TTM revenue is not available.
Performance
MTNB TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
MTNB Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -65.6% | - | - |
| 3 y3 years | +592.4% | - | - |
| 5 y5 years | +815.6% | - | - |
MTNB Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -65.6% | +3221.2% | ||||
| 5 y | 5-year | -65.6% | +3221.2% | ||||
| alltime | all time | -65.6% | +3221.2% |
Matinas BioPharma Holdings Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $1.10 M(-65.6%) | - | - |
| Mar 2023 | - | $1.10 M(+3.1%) | $4.29 M(+34.4%) |
| Dec 2022 | $3.19 M(+9560.6%) | $1.06 M(0.0%) | $3.19 M(+50.0%) |
| Sep 2022 | - | $1.06 M(0.0%) | $2.13 M(+100.0%) |
| Jun 2022 | - | $1.06 M(<-9900.0%) | $1.06 M(+3120.3%) |
| Dec 2021 | $33.00 K(-79.2%) | -$300.00(-100.9%) | $33.00 K(-82.8%) |
| Mar 2021 | - | $33.30 K(-46.7%) | $191.60 K(+21.0%) |
| Dec 2020 | $158.30 K(+76.3%) | $62.50 K(-34.8%) | $158.30 K(+65.2%) |
| Sep 2020 | - | $95.80 K(+6.7%) | $95.80 K(+6.7%) |
| Dec 2019 | $89.80 K(-25.0%) | - | - |
| Jun 2019 | - | $89.80 K | $89.80 K |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $119.70 K(-20.0%) | - | - |
| Jun 2018 | - | $89.80 K(+200.3%) | $209.50 K(+27.3%) |
| Mar 2018 | - | $29.90 K(-33.4%) | $164.60 K(+10.0%) |
| Dec 2017 | $149.70 K(-23.0%) | $44.90 K(0.0%) | $149.70 K(+42.8%) |
| Sep 2017 | - | $44.90 K(0.0%) | $104.80 K(+75.0%) |
| Jun 2017 | - | $44.90 K(+199.3%) | $59.90 K(+299.3%) |
| Mar 2017 | - | $15.00 K(-75.0%) | $15.00 K(-92.3%) |
| Dec 2015 | $194.50 K | - | - |
| Sep 2015 | - | $59.90 K(-22.2%) | $194.50 K(+44.5%) |
| Jun 2015 | - | $77.00 K(+33.7%) | $134.60 K(+133.7%) |
| Mar 2015 | - | $57.60 K | $57.60 K |
FAQ
- What is Matinas BioPharma Holdings annual revenue?
- What is the all time high annual revenue for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual revenue year-on-year change?
- What is the all time high quarterly revenue for Matinas BioPharma Holdings?
- What is the all time high TTM revenue for Matinas BioPharma Holdings?
What is Matinas BioPharma Holdings annual revenue?
The current annual revenue of MTNB is $1.10 M
What is the all time high annual revenue for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual revenue is $3.19 M
What is Matinas BioPharma Holdings annual revenue year-on-year change?
Over the past year, MTNB annual revenue has changed by -$2.09 M (-65.62%)
What is the all time high quarterly revenue for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly revenue is $1.10 M
What is the all time high TTM revenue for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high TTM revenue is $4.29 M